Quantcast
Last updated on April 20, 2014 at 0:02 EDT

Latest Pre-clinical development Stories

2014-04-16 09:48:04

Over 20 years after the fatal fialuridine trial, a study published this week in PLOS Medicine demonstrates that mice with humanized livers recapitulate the drug's toxicity. The work suggests that this mouse model should be added to the repertoire of tools used in preclinical screening of drugs for liver toxicity before they are given to human participants in clinical trials. A retrospective analysis by the US National Academy of Sciences of all preclinical fialuridine toxicity tests, which...

2014-04-08 16:22:55

Exec to Support Life Science Research Clients in Booming Southwestern Market SALT LAKE CITY, April 8, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. "As we've seen remarkable growth opportunities in the western United States, we knew we needed to bring on new and exceptional...

2014-03-11 04:21:27

BARCELONA, Spain, March 11, 2014 /PRNewswire/ -- - This gene therapy program is being developed in a public-private partnership between ESTEVE and the research team of Dr. Fatima Bosch at the Center for Biotechnology and Gene Therapy of the Universitat Autonoma de Barcelona (UAB) - ESTEVE announce the signing of agreements with REGENX and GENETHON which will allow it to initiate its phase I/II clinical trial in 2015 -...

2014-01-22 23:23:03

Xtalks presents an exciting live webinar on Thursday, February 13, 2014 at 11:00am EST (16:00 GMT). Join keynote speakers Aysha Akhtar, Fellow, Oxford Centre for Animal Ethics, and Medical Officer, Food and Drug Administration, and Dr. Toby Gill, Independent Nanotechnology Professional, UK, for a one-hour discussion on alternatives to animal testing methods. Toronto, Canada (PRWEB) January 22, 2014 The presenters will discuss scientific and ethical imperatives associated with the use of...

2014-01-20 23:04:45

Xtalks present a new and informative webinar that focuses on how to use increasingly intricate and sophisticated procedures for intravenous infusion in the preclinical and clinical perspectives as well as new ideas on attending to animal welfare. This webinar takes place on Wednesday, February 5, 2014 at 9am EST (2pm GMT). Toronto, Canada (PRWEB) January 20, 2014 Preclinical studies for drug candidates should reflect as closely as possible the clinical regimen with respect to route,...

2013-11-20 08:28:59

HAMILTON, N.J., Nov. 20, 2013 /PRNewswire/ -- Invivotek, LLC is the proud recipient of the Innovation and Achievement Award recognizing excellence in animal facility design, planning, construction and operation. The Award was presented by Allentown, Inc., a leader in design and installation in quality animal housing. Invivotek, a member of the Genesis Biotechnology Group(TM), is a pre-clinical Contract Research Organization focused on phenotypic characterization of genetically...

2013-10-14 08:24:09

IRVINE, Calif., Oct. 14, 2013 /PRNewswire/ -- GZP announces its V-Team(TM). An increasing proportion of small firms with innovative drug, biologic and vaccine programs are remaining virtual as long as possible, to conserve funding and apply it directly to the generation of data that will hold the attention of Regulators and bring in additional investors. While employees are "owned" by a firm, the overhead to retain them leads to a high burn rate. An employee may be an expert in his or her...

2013-08-31 23:01:50

Come discuss your preclinical needs with Integral BioSystems CEO/CSO Shikha P. Barman, Ph.D. at the Hyatt Regency in New Brunswick, NJ, September 19 and 20, 2013 to discuss how Integral BioSystems’ pharmaceutical formulation capabilities can help your firm to develop medications for the treatment of disease of the front and back of the eye using the firm’s advanced platform ophthalmic formulation technologies. Bedford, Massachusetts (PRWEB) August 31, 2013 Integral BioSystems LLC, led...

2013-07-24 11:24:48

Less than five percent of promising basic science discoveries that claim clinical relevance lead to approved drugs within a decade, partly because of flawed pre-clinical animal research. A number of recent initiatives seek to improve the quality of such studies, and an article published this week in PLOS Medicine identifies key experimental procedures believed to increase clinical generalizability. The authors, led by Jonathan Kimmelman of McGill University in Montréal, did a...

2013-06-29 23:01:39

In response to increased client demand and the expansion of the company’s internal product development programs, Integral BioSystems has expanded both its laboratory and office facilities to accommodate a 33 percent increase in headcount with attendant increase in its analytical equipment holdings Bedford, Massachusetts (PRWEB) June 29, 2013 The markets have spoken, and Integral BioSystems LLC, led by 20+ year veteran of drug formulation development Shikha P. Barman, Ph.D., with its...